EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
10.76 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||||||
Current Assets: | ||||||||||||||||||||||
Cash & Cash Equivalents
| 281.263 | 95.633 | 178.593 | 44.909 | 22.214 | 38.776 | 16.898 | 15.313 | 19.121 | 15.334 | 6.899 | 4.625 | 12.912 | 15.514 | 6.899 | 15.609 | 2.668 | 11.469 | 9.79 | 21.786 | 0.793 | 1.643 |
Short Term Investments
| 49.787 | 48.928 | 32.965 | 0 | 0 | 0 | 0 | 13.679 | 9.414 | 2.944 | 3.374 | 9.946 | 11.216 | 2.051 | 2.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 331.05 | 144.561 | 211.558 | 44.909 | 22.214 | 38.776 | 16.898 | 28.992 | 28.535 | 18.278 | 10.273 | 14.571 | 24.128 | 17.565 | 6.899 | 15.609 | 2.668 | 11.469 | 9.79 | 21.786 | 0.793 | 1.643 |
Net Receivables
| 0.805 | 15.503 | 18.354 | 9.453 | 11.368 | 0.353 | 0.353 | 0.251 | 0.488 | 0.622 | 0.517 | 0.597 | 0.967 | 0.843 | 1.111 | 0.815 | 1.467 | 2.508 | 0.743 | 0.237 | 0.069 | 0.082 |
Inventory
| 3.906 | 2.886 | 3.616 | 5.337 | 2.138 | -0.353 | -0.251 | -0.488 | -0.622 | 0 | -0.597 | -0.967 | -0.843 | -1.111 | 0 | 0 | 0.513 | 0.469 | 0 | 0 | 0 | 0 |
Other Current Assets
| 9.039 | 18.934 | 7.917 | 6.838 | 5.997 | 2.567 | 0.78 | 0.591 | 0.483 | 0.681 | 0.547 | 1.594 | 0.421 | 0.395 | 0.358 | 0.413 | 0.614 | 0.513 | 0.47 | 0.245 | 0.027 | 0.006 |
Total Current Assets
| 344.8 | 172.808 | 237.745 | 63.118 | 42.069 | 39.909 | 17.74 | 29.963 | 29.838 | 19.342 | 12.464 | 15.959 | 25.366 | 19.034 | 8.127 | 17.69 | 5.688 | 12.682 | 10.574 | 22.049 | 0.88 | 1.732 |
Non-Current Assets: | ||||||||||||||||||||||
Property, Plant & Equipment, Net
| 10.234 | 6.038 | 2.252 | 3.24 | 3.078 | 0.253 | 0.313 | 0.29 | 0.338 | 0.297 | 0.179 | 0.335 | 0.123 | 0.043 | 0.066 | 0.473 | 0.511 | 2.331 | 2.486 | 0.465 | 0.272 | 0.38 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.498 | 39.471 | 973.923 | 973.923 | 0 | 0 |
Intangible Assets
| 0 | 0 | 22.749 | 25.209 | 27.669 | 31.358 | 0.364 | 1.102 | 1.925 | 2.765 | 3.43 | 4.226 | 21.564 | 23.877 | 28.802 | 36.802 | 39.42 | 120.365 | 49.237 | 5.514 | 3.626 | 2.608 |
Goodwill and Intangible Assets
| 0 | 0 | 22.749 | 25.209 | 27.669 | 31.358 | 0.364 | 1.102 | 1.925 | 2.765 | 3.43 | 4.226 | 21.564 | 23.877 | 28.802 | 36.802 | 79.918 | 159.835 | 49.237 | 5.514 | 3.626 | 2.608 |
Long Term Investments
| 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0 | 0.15 | 0.15 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | -0.15 | -0.15 | -0.15 | -0.15 | 0 | -0.15 | -0.15 | -0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 1.36 | 0.626 | 0.15 | 0.507 | 0.15 | 0.26 | 0.264 | 0.266 | 0.267 | 0.176 | 0.077 | 0.06 | 0.06 | 0.109 | 0.819 | 0.001 | 0 | 0 | 0.023 | 0.043 | 0 |
Total Non-Current Assets
| 10.384 | 7.548 | 25.627 | 28.599 | 31.254 | 31.761 | 0.937 | 1.656 | 2.529 | 3.329 | 3.785 | 4.638 | 21.747 | 23.98 | 28.977 | 38.094 | 80.43 | 162.166 | 51.723 | 6.002 | 3.941 | 2.987 |
Total Assets
| 355.184 | 180.356 | 263.372 | 91.717 | 73.323 | 71.67 | 18.677 | 31.619 | 32.367 | 22.671 | 16.249 | 20.597 | 47.113 | 43.014 | 37.104 | 55.784 | 86.118 | 174.848 | 62.298 | 28.051 | 4.82 | 4.719 |
Liabilities & Equity: | ||||||||||||||||||||||
Current Liabilities: | ||||||||||||||||||||||
Account Payables
| 6.504 | 5.919 | 7.385 | 4.811 | 4.192 | 2.64 | 2.94 | 1.016 | 1.363 | 0.744 | 0.464 | 0.671 | 0.394 | 0.328 | 0.387 | 0.284 | 2.634 | 7.536 | 5.506 | 1.532 | 0.808 | 0 |
Short Term Debt
| 0 | 11.054 | 0.782 | 0.687 | 0.962 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.331 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 38.592 | 1.205 | 1.069 | 0.945 | 0.015 | 0.03 | 0.05 | 0.147 | 0.033 | 0.138 | 0.738 | 2.176 | 3.212 | 0.079 | 5.912 | 10.476 | 1.7 | 1.981 | 2,668.574 | 0 | 0 | 0 |
Other Current Liabilities
| 18.167 | 16.359 | 14.422 | 8.445 | 6.351 | 18.789 | 2.35 | 4.224 | 3.583 | 2.571 | 1.524 | 1.894 | 0.608 | 1.492 | 2.468 | 2.523 | 4.166 | 9.9 | 1.974 | 0.023 | -0.219 | 0.146 |
Total Current Liabilities
| 63.263 | 34.537 | 23.658 | 14.888 | 11.872 | 21.663 | 5.29 | 5.093 | 3.348 | 2.126 | 3.303 | 3.178 | 5.032 | 2.934 | 8.719 | 17.276 | 18.086 | 17.792 | 1.555 | 1.347 | 0.588 | 0.146 |
Non-Current Liabilities: | ||||||||||||||||||||||
Long Term Debt
| 4.906 | 35.294 | 38.422 | 40.307 | 50.121 | 17.309 | 17.309 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.146 |
Deferred Revenue Non-Current
| 20.692 | 13.557 | 14.56 | 15.616 | 0 | 0 | 0 | 5.585 | 5.596 | 5.584 | 5.246 | 3.783 | 4.635 | 6.817 | 4.622 | 8.114 | 8.114 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.013 | 0.222 | 0.222 | 0.316 | 2.125 | 24.169 | 32,550.78 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0.6 | 2.352 | 2.365 | 3 | 21.011 | -17.258 | 0.051 | 0.06 | 0.055 | 5.621 | 0 | 0 | 0 | 0 | 0 | 0 | 2.926 | 2.925 | 0 | 0 | -0.146 |
Total Non-Current Liabilities
| 25.598 | 49.451 | 55.334 | 58.288 | 53.121 | 38.32 | 0.051 | 5.645 | 5.651 | 5.621 | 5.246 | 3.783 | 4.648 | 7.039 | 4.844 | 8.43 | 2.125 | 27.094 | 1.494 | 0.808 | 0.363 | -0 |
Total Liabilities
| 88.861 | 83.988 | 78.992 | 73.176 | 64.993 | 59.983 | 5.341 | 10.738 | 8.999 | 7.747 | 8.549 | 6.961 | 9.68 | 9.973 | 13.563 | 25.706 | 20.211 | 44.887 | 1.555 | 1.347 | 0.588 | 0.146 |
Equity: | ||||||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.049 | 766.933 | 752.636 | 528.38 | 472.776 | 374.84 | 323.323 | 312.242 | 293.089 | 0.029 | 270.438 | 264.452 | 262.927 | 250.815 | 0.018 | 0.018 | 0.018 | 0 | 81.927 | 34.716 | 10.482 | 6.179 |
Retained Earnings
| -742.146 | -671.351 | -569.097 | -510.68 | -465.286 | -363.991 | -310.82 | -292.213 | -270.666 | -277.013 | -263.658 | -251.758 | -226.923 | -218.295 | -227.048 | -224.537 | -151.95 | -42.269 | -21.2 | -9.166 | -6.387 | -2.308 |
Accumulated Other Comprehensive Income/Loss
| 0.864 | 0.786 | 0.841 | 0.841 | 0.84 | 0.838 | 0.833 | 0.852 | 0.945 | 1.044 | 0.92 | 0.942 | 1.429 | 0.521 | 2.071 | 6.969 | 10.91 | 1.176 | 0.016 | 0.054 | 0 | 0 |
Other Total Stockholders Equity
| 1,007.556 | 766.899 | 752.602 | 528.362 | 472.765 | 419.247 | 376.415 | 323.284 | 312.208 | 293.06 | 290.864 | 270.415 | 264.431 | 262.906 | 250.796 | 248.5 | 247.628 | 271.624 | 101.836 | 47.01 | 0 | 0.703 |
Total Shareholders Equity
| 266.323 | 96.368 | 184.38 | 18.541 | 8.33 | 11.687 | 13.336 | 20.881 | 23.368 | 14.924 | 7.7 | 13.636 | 37.433 | 33.041 | 23.541 | 30.078 | 65.907 | 129.962 | 60.743 | 25.604 | 4.095 | 4.573 |
Total Equity
| 266.323 | 96.368 | 184.38 | 18.541 | 8.33 | 11.687 | 13.336 | 20.881 | 23.368 | 14.924 | 7.7 | 13.636 | 37.433 | 33.041 | 23.541 | 30.078 | 65.907 | 129.962 | 60.743 | 26.704 | 4.232 | 4.573 |
Total Liabilities & Shareholders Equity
| 355.184 | 180.356 | 263.372 | 91.717 | 73.323 | 71.67 | 18.677 | 31.619 | 32.367 | 22.671 | 16.249 | 20.597 | 47.113 | 43.014 | 37.104 | 55.784 | 86.118 | 174.848 | 62.298 | 28.051 | 4.82 | 4.719 |